Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

Phase II results announced for DX-890 in children with cystic fibrosis

Feb. 26, 2004

New synthetic isoflavone derivative inhibits asthma in vivo

Feb. 26, 2004

AstraZeneca scientists identify novel CRTh2 receptor modulators

Feb. 25, 2004

Two series of macrolide-containing antiinflammatory agents developed at Pliva

Feb. 25, 2004

Clinical benefits induced by roflumilast in the treatment of asthma

Feb. 24, 2004

Surfaxin selected for CMA Pilot 2 Program

Feb. 24, 2004

Enrollment completed in phase IIa IPL-512602 study

Feb. 24, 2004

Novel PDE4 inhibitors and their use described by Merck Frosst scientists

Feb. 23, 2004

Assessment of the efficacy and safety of ciclesonide during the 4th World Asthma Meeting

Feb. 20, 2004

Novel CCR3 antagonists for asthma therapy claimed by Roche

Feb. 20, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 20, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...